Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia |
Avagyan, Armen
(Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University)
Danielyan, Samvel (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Voskanyan, Astghik (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Sargsyan, Lilit (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Hakobyan, Lusine (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Zohrabyan, Davit (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Safaryan, Liana (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Harutyunyan, Lilit (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Bardakchyan, Samvel (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Iskanyan, Samvel (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Arakelyan, Samvel (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) Tamamyan, Gevorg (Department of Oncology, Yerevan State Medical University and Clinic of Chemotherapy, Muratsan University Hospital, Yerevan State Medical University) |
1 | Andjelic B, Antic D, Jakovic L, et al (2014). A single institution experience on 314 newly diagnosed advanced hodgkin lymphoma patients: the role of ABVD in daily practice. Eur J Haematol, 93, 392-99. DOI |
2 | Baharvand M, Mortazavi H (2014). Characteristics of Hodgkin lymphoma in a defined group of iranian pediatric patients. Asian Pac J of Cancer Prev, 15, 5167-69. DOI |
3 | Bosetti C, Levi F, Ferlay J, et al (2009). The recent decline in mortality from hodgkin lymphomas in central and eastern europe. Ann Oncol, 20, 767-74. DOI |
4 | Carbone P, Kaplan H, Musshoff K, et al (1971). Report of the committee on hodgkin's disease staging classification. Cancer Res, 31, 1860-61. |
5 | DeSantis C, Lin C, Mariotto A, et al (2014). Cancer Treatment and Survivorship Statistics. CA Cancer J Clin, 64, 252-71. DOI |
6 | Dinand V, Arya L (2006). Epidemiology of childhood hodgkins disease: is it different in developing countries? Indian Pediatr, 43, 141-47. |
7 | Fadhil M, Al-Nueimy W, Lazim A (2014). Hodgkin's lymphoma. an immunohistochemical profile in Northern Iraq. Saudi Med J, 35, 448-53. |
8 | Foss Abrahamsen A, Egeland T, Hansen S, et al (1997). Hodgkin's disease in a national and hospital population: trends over 20 years. Eur J Cancer, 33, 2380-83. DOI |
9 | Geller S, Taylor C (2013). Thomas hodgkin: the 'man' and 'his disease': humani nihil a se alienum putabit (nothing human was foreign to him). Virchows Arch, 463, 353-65. DOI |
10 | Gender Statistics. Highlights from (2012). World Development Report (2012). [Online]. |
11 | Georgii A, Fischer R, Hubner K, et al (1993). Classification of hodgkin's disease biopsies by a panel of four histopathologists. report of 1,140 patients from the German National Trial. Leuk Lymphoma, 9, 365-70. DOI |
12 | Hakobyan T, Nazaretyan M, Makarova T, et al (2006). Armenia: health system review. Health Syst Transit, 8, 1-202. |
13 | Harris N (1999). Hodgkin's lymphomas: classification, diagnosis, and grading. Semin Hematol, 36, 220-32. |
14 | Hessissen L, Khtar R, Madani A, et al (2013). Improving the prognosis of pediatric hodgkin lymphoma in developing countries: a moroccan society of pediatric hematology and oncology study. Pediatr Blood Cancer, 60, 1464-69 DOI |
15 | National Statistical Service of Republic of Armenia (2015). [Online]. |
16 | Lee M, Tan T, Feng A (2005). Clinico-pathological study of hodgkin's lymphoma in a cancer center in Taiwan. Clin Lab Haematol, 27, 379-83. DOI |
17 | Lister T, Crowther D, Sutcliffe S, et al (1989). Report of a committee convened to discuss the evaluation and staging of patients with hodgkin's disease: cotswolds meeting. J Clin Oncol, 7, 1630-66. DOI |
18 | Macfarlane G, Evstifeeva T, Boyle P, et al (1995). International patterns in the occurrence of hodgkin's disease in children and young adult males. Int J Cancer, 61, 165-69. DOI |
19 | NCCN Clinical Practice Guidelines in Oncology. Hodgkin Disease/Lymphoma (2008). Vol 2. [Online]. |
20 | Olu-Eddo A, Omoti C (2011). Hodgkin lymphoma: clinicopathologic features in benin city, nigeria and update on its biology and classification. Niger J Clin Pract, 14, 440-44. DOI |
21 | Ramadas K, Sankaranarayanan R, Nair M, et al (1994). Adult Hodgkin's disease in Kerala. Cancer, 73, 2213-17. DOI |
22 | Richardson E (2013). Armenia: health system review. Health Syst Transit, 15, 1-99. |
23 | Riyat M (1992). Hodgkin's disease in Kenya. Cancer, 69, 1047-51. DOI |
24 | Sant M, Allemani C, Tereanu C, et al (2010). Incidence of hematologic malignancies in europe by morphologic subtype: results of the haemacare project. Blood, 116, 3724-34. DOI |
25 | SEER 18 Stat Fact Sheets (2008-2012) - Hodgkin lymphoma. [Online]. |
26 | Sughayer M, Haddad H, Al-Yousef R, et al (2014). Epstein-barr virus and hodgkin lymphoma in Jordan. Hematol Oncol Stem Cell Ther, 7, 85-89. DOI |
27 | Sherief L, Elsafy U, Abdelkhalek E, et al (2015). Hodgkin lymphoma in childhood: clinicopathological features and therapy outcome at 2 centers from a developing country. Med, 94, 670 DOI |
28 | Shimabukuro-Vornhagen A, Haverkamp H, Engert A (2005). Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within german hodgkin's study group trials. J Clin Oncol, 23, 5739-45. DOI |
29 | Siddiqui N, Ayub B, Badar F, et al (2006). Hodgkin's lymphoma in Pakistan: a clinico-epidemiological study of 658 cases at a cancer center in Lahore. Asian Pac J Cancer Prev, 7, 651-55. |
30 | Swerdlow S, Campo E, Harris N, et al (2008). WHO classification of tumours of haematopoietic and lymphoid tissues. IARC WHO Classification of Tumours, 2, 1-439. |
31 | Torre L, Bray F, Siegel R, et al (2015). Global Cancer Statistics, 2012. CA Cancer J Clin, 65, 87-108. DOI |
32 | World Health Organization Global Health Expenditure Database 2010-2014 (2015). [Online]. |
33 | Yaqo R , Hughson M, Sulayvani F, et al (2011). Malignant lymphoma in northern Iraq: a retrospective analysis of 270 cases according to the world health organization classification. Indian J Cancer, 48, 446-51 DOI |
![]() |